Immix Biopharma, Inc. IMMX Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s preferred stock, par or stated value per share?
- Immix Biopharma, Inc. (IMMX) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Immix Biopharma, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Immix Biopharma, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Immix Biopharma, Inc.'s preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.